Promoter hypermethylation of tumour suppressor genes (p14/ARF and p16/INK4a): case–control study in North Indian population

[1]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[2]  Jian Jiang,et al.  [Methylation and expression of gene p16INK4a and RB in breast carcinoma]. , 2010, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[3]  C. Marian,et al.  Familial and racial determinants of tumour suppressor genes promoter hypermethylation in breast tissues from healthy women , 2009, Journal of cellular and molecular medicine.

[4]  M. Shahid,et al.  Promoter Hypermethylation in Tumor Suppressing Genes p16 and FHIT and Their Relationship with Estrogen Receptor and Progesterone Receptor Status in Breast Cancer Patients from Northern India. , 2009, Translational oncology.

[5]  S. Mirza,et al.  Prognostic Relevance of Promoter Hypermethylation of Multiple Genes in Breast Cancer Patients , 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[6]  S. Clark,et al.  Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. , 2009, Human molecular genetics.

[7]  Pooja Ramakant,et al.  Breast Cancer Care in Developing Countries , 2009, World Journal of Surgery.

[8]  Anurag Srivastava,et al.  Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients. , 2008, Life sciences.

[9]  G. Agarwal,et al.  Breast Cancer Care in India: The Current Scenario and the Challenges for the Future , 2008, Breast Care.

[10]  D. Lane,et al.  Regulation of the p14ARF promoter by DNA methylation , 2008, Cell cycle.

[11]  Douglas F. Easton,et al.  Age at Menarche and Menopause and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[12]  F. Prósper,et al.  Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome , 2006, Leukemia.

[13]  Megan F. Cole,et al.  Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.

[14]  K. Kawamoto,et al.  p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. , 2006, Biochemical and biophysical research communications.

[15]  Mitsutoshi Nakamura,et al.  Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma. , 2005, Oral oncology.

[16]  J. O’Leary,et al.  P16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem , 2004, Virchows Archiv.

[17]  Chih-Yi Chen,et al.  CpG Island Methylation Is Responsible for p14ARF Inactivation and Inversely Correlates with p53 Overexpression in Resected Non–Small Cell Lung Cancer , 2004, Clinical Cancer Research.

[18]  D. Kelsell,et al.  p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. , 2004, The Journal of investigative dermatology.

[19]  R. Uzzo,et al.  Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel , 2004, Clinical Cancer Research.

[20]  Luoping Zhang,et al.  Hypermethylation of the 5′ CpG Island of the FHIT Gene Is Associated with Hyperdiploid and Translocation-Negative Subtypes of Pediatric Leukemia , 2004, Cancer Research.

[21]  E. Sauter,et al.  Detection of Breast Cancer in Nipple Aspirate Fluid by CpG Island Hypermethylation , 2004, Clinical Cancer Research.

[22]  Jose M. Silva,et al.  Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors. , 2003, Mutation research.

[23]  G. Watanabe,et al.  Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival. , 2003, Oncology reports.

[24]  Yi Ding,et al.  Methylation and mutation analysis of p16 gene in gastric cancer. , 2003, World journal of gastroenterology.

[25]  E. Yu,et al.  p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis. , 2003, Cancer letters.

[26]  S. Lowe,et al.  Tumor suppression by Ink4a-Arf: progress and puzzles. , 2003, Current opinion in genetics & development.

[27]  P. Guldberg,et al.  DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy. , 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[28]  Susan J Clark,et al.  DNA methylation and gene silencing in cancer: which is the guilty party? , 2002, Oncogene.

[29]  M. Esteller.  CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.

[30]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[31]  R. Weinberg,et al.  Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.

[32]  C. Croce,et al.  FHIT gene therapy prevents tumor development in Fhit-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  F. Bosman,et al.  Methylation Silencing and Mutations of the p14ARF and p16INK4a Genes in Colon Cancer , 2001, Laboratory Investigation.

[34]  G. Kang,et al.  Correlation of p16 Hypermethylation with p16 Protein Loss in Sporadic Gastric Carcinomas , 2000, Laboratory Investigation.

[35]  K McPherson,et al.  ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. , 2000, BMJ.

[36]  G. Yang,et al.  Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  J. Herman,et al.  Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. , 1999, Cancer research.

[38]  J. Fagin,et al.  Genetic and epigenetic alterations of the cyclin‐dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas , 1998, Cancer.

[39]  Peter A. Jones,et al.  The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53 , 1998, Molecular and Cellular Biology.

[40]  A. Kimchi.  DAP genes: novel apoptotic genes isolated by a functional approach to gene cloning. , 1998, Biochimica et biophysica acta.

[41]  V. Gouyer,et al.  Mechanisms of p16INK4A inactivation in non small-cell lung cancers , 1998, Oncogene.

[42]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  F. Zindy,et al.  Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.